Buy or sell Transcriptic stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies

Transcriptic Stock
Transcriptic is a SaaS-based biotechnology company providing robotic solutions for biology labs.
About Transcriptic Stock
Transcriptic is a new kind of scientific outsourcing provider. By expressing life science methods as data, infrastructure virtualization will become possible. "Science-as-a-Service" will power the next generation of discovery, driven by huge efficiencies of both time and money. Transcriptic was founded in 2012 to create a better way to get lab work done. Tired of spending endless hours at the bench pretending to be slow, error-prone robots, they set out to build a modern solution to the day-to-day process of wet lab biology. Drawing on deep computer science and electrical engineering backgrounds in addition to life science, Transcriptic was born: a meticulously optimized, technology-enabled remote lab. Using state-of-the-art automation and control technology, and an emphasis on user experience and usability, they are working on building a stark contrast to the long, complicated sales process, high prices, and slow turnarounds of traditional CROs. Molecular cloning is just the beginning. They are working hard to build a great company that can be a true partner for your lab for a long time, progressively enabling ever greater levels of productivity and efficiency. They are scientists building for scientists.
Funding History
November 2012 | $0 |
---|---|
November 2012 | $1.2M |
February 2014 | $2.8M |
July 2014 | $1.8M |
December 2014 | $120K |
February 2015 | $8.5M |
November 2016 | $13.4M |
Management
Head of Scientific Operations
Yin He
Head of Sales
Ginger Cooper
VP of Engineering, Hardware
Jimmy Sastra
CEO
Yvonne Linney
Founder & Chief Executive Officer
Max Hodak
VP Engineering, Software
Evan Worley
Press
Business Wire (press release) - May, 10 2018
GenomeWeb - Apr, 12 2018
Forbes - Dec, 21 2017
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase